|
gptkbp:instanceOf
|
gptkb:brand
contraceptive medication
|
|
gptkbp:activeIngredient
|
gptkb:medroxyprogesterone_acetate
|
|
gptkbp:alternativeName
|
gptkb:Depo
gptkb:DMPA
gptkb:Depo_shot
medroxyprogesterone injection
|
|
gptkbp:approvalYear
|
1992
|
|
gptkbp:ATCCode
|
gptkb:G03AC06
|
|
gptkbp:category
|
long-acting reversible contraceptive
progestin-only contraceptive
|
|
gptkbp:contraindication
|
gptkb:cancer
gptkb:liver_disease
pregnancy
unexplained vaginal bleeding
|
|
gptkbp:countryOfOperation
|
gptkb:Australia
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:duration
|
about 3 months
|
|
gptkbp:effectOnFertility
|
temporary suppression
|
|
gptkbp:eliminationHalfLife
|
50 days
|
|
gptkbp:form
|
104 mg/0.65 mL suspension
150 mg/mL suspension
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Depo-Provera
|
|
gptkbp:indication
|
gptkb:endometrial_cancer
birth control
abnormal uterine bleeding
endometriosis
menstrual disorders
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:marketedAs
|
1960s
|
|
gptkbp:pregnancyCategory
|
gptkb:X_(US)
|
|
gptkbp:prescriptionRequired
|
yes
|
|
gptkbp:returnToFertility
|
may take 6-12 months after last injection
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
subcutaneous injection
|
|
gptkbp:sideEffect
|
headache
decreased libido
mood changes
weight gain
bone density loss
irregular menstruation
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:usedIn
|
family planning
hormonal therapy
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Sayana_Press
gptkb:Pharmacia_&_Upjohn
|
|
gptkbp:bfsLayer
|
6
|